Your browser doesn't support javascript.
loading
Relation of beclin-1 and bcl-2 expressions with pathological parameters and prognosis in clear cell renal cell carcinomas
Girgin, Rabia Burcin; Ozkanli, Seyma; Engin-Zerk, Pinar; Soylemez, Tuce; Olgun, Zeynep Cagla; Yildirim, Asif; Kir, Gozde.
Affiliation
  • Girgin, Rabia Burcin; Malatya Research and Training Hospital. Department of Pathology. Turkey
  • Ozkanli, Seyma; Istanbul Medeniyet University Göztepe Prof. Dr. Suleyman Yalcin City Hospital. Department of Pathology. Turkey
  • Engin-Zerk, Pinar; Istanbul Medeniyet University Göztepe Prof. Dr. Suleyman Yalcin City Hospital. Department of Pathology. Turkey
  • Soylemez, Tuce; Basaksehir Cam and Sakura City Hospital. Depatment of Pathology. Turkey
  • Olgun, Zeynep Cagla; Istanbul Medeniyet University Göztepe Prof. Dr. Suleyman Yalcin City Hospital. Department of Pathology. Turkey
  • Yildirim, Asif; Istanbul Medeniyet University Göztepe Prof. Dr. Suleyman Yalcin City Hospital. Department of Urology. Turkey
  • Kir, Gozde; Istanbul Medeniyet University Göztepe Prof. Dr. Suleyman Yalcin City Hospital. Department of Pathology. Turkey
Arch. esp. urol. (Ed. impr.) ; 75(4): 368-374, May 28, 2022. tab, graf
Article in English | IBECS | ID: ibc-209218
Responsible library: ES1.1
Localization: ES15.1 - BNCS
ABSTRACT

Introduction:

The most common type of renal cancers is the clear cell renal cell carcinoma (CCRCC) and 98% of CCRCCshave a loss of sequence in the short arm of chromosome 3 by deletion or translocation. Programmed cell death; another possiblemechanism of tumorigenesis, comprises two separate components apoptosis and autophagy. This study aims to show the relation between the prognostic parameters and survival, and Beclin-1, as the representative marker of autophagy, and Bcl-2 as therepresentative marker of apoptosis in CCRCC patients. In this study, we aimed to determine if Beclin-1 and Bcl-2 expressionlevels can provide any prognostic information about CCRCC patients.

Methods:

We examined a total of 84 patients who underwent partial or radical nephrectomy and were diagnosed as havingCCRCC between January 2008 and December 2015. Immunohistochemical staining was performed, the evaluation was forBeclin-1 and Bcl-2 semi-quantitative, and based on the percentage of positively stained cells (proportion) and staining intensity.

Results:

There was only a statistical significance between Beclin-1 expression and age (r-0.274; p=0.012; p <0.05). There wasa marginal significance between ISUP grade and Beclin-1 (p=0.051). The relation of Bcl-2 expression with the ISUP grade,recurrence, metastasis, and mortality revealed statistical significance (p=0.001, p=0.019, p=0.009, p=0.013, respectively). TheISUP grade and the Bcl-2 expression revealed statistical significance on multivariate analysis ( HR 7.453, 95% CI 1.935-28.713,p=0.004). The 5-year and 10-year tumor recurrences rates were lower in Bcl-2 positive group, and Bcl-2 positive group experienced longer disease free and overall survival...(AU)
Subject(s)

Search on Google
Collection: National databases / Spain Database: IBECS Main subject: Carcinoma, Renal Cell / Proto-Oncogene Proteins c-abl / Beclin-1 / Kidney Neoplasms Limits: Adult / Aged / Female / Humans / Male Language: English Journal: Arch. esp. urol. (Ed. impr.) Year: 2022 Document type: Article Institution/Affiliation country: Basaksehir Cam and Sakura City Hospital/Turkey / Istanbul Medeniyet University Göztepe Prof. Dr. Suleyman Yalcin City Hospital/Turkey / Malatya Research and Training Hospital/Turkey
Search on Google
Collection: National databases / Spain Database: IBECS Main subject: Carcinoma, Renal Cell / Proto-Oncogene Proteins c-abl / Beclin-1 / Kidney Neoplasms Limits: Adult / Aged / Female / Humans / Male Language: English Journal: Arch. esp. urol. (Ed. impr.) Year: 2022 Document type: Article Institution/Affiliation country: Basaksehir Cam and Sakura City Hospital/Turkey / Istanbul Medeniyet University Göztepe Prof. Dr. Suleyman Yalcin City Hospital/Turkey / Malatya Research and Training Hospital/Turkey
...